SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
3Y CAGR-8.3%
5Y CAGR-5.9%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-8.3%/yr
Annual compound
5Y CAGR
-5.9%/yr
Consistent
Percentile
P0
Near historical low
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
202533.87%-12.9%
202438.90%-8.9%
202342.72%-2.7%
202243.89%+0.6%
202143.65%-4.7%
202045.78%-0.6%
201946.07%-